Nagy Z, Liu J, Cecile J, Silber S, Devroey P, Van Steirteghem A
Centre for Reproductive Medicine, University Hospital, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel), Belgium.
Fertil Steril. 1995 Apr;63(4):808-15. doi: 10.1016/s0015-0282(16)57486-x.
To describe the preparation of fresh or frozen-thawed epididymal and testicular sperm for intracytoplasmic single sperm injection and to compare the fertilization, embryo quality, and pregnancy rates (PRs) obtained after using these spermatozoa to the results when freshly ejaculated sperm was used for microinjection.
Retrospective analysis of 1,034 consecutive microinjection cycles. Ejaculated (965 cycles), fresh epididymal (43 cycles), frozen-thawed epididymal (9 cycles), and testicular sperm (17 cycles) was used for intracytoplasmic sperm injection.
Procedures were performed in a tertiary IVF center coupled with an institutional research environment.
Semen density and motility were judged by the World Health Organization criteria and sperm morphology was evaluated by the Tygerberg's strict criteria. After microinjection, oocyte intactness, fertilization, embryo cleavage, transfer, and PRs were evaluated and compared.
The median values of total sperm count, total motility and normal morphology were 17.85 x 10(6), 37%, 8% for freshly ejaculated sperm; 46.20 x 10(6), 12%, 9% for fresh epididymal sperm; 0.15 x 10(6), 0%, 0% for frozen-thawed epididymal sperm; and 0.54 x 10(6), 0% for testicular sperm (morphology was not determined). The percentage of intact oocytes after microinjection ranged from 84% to 90%. Normal fertilization rates were high when fresh or frozen-thawed epididymal and testicular spermatozoa were used for the injection (56%, 56%, 48%, respectively) but were significantly lower than for ejaculated sperm (70%). There was a higher proportion of transferable embryos obtained after ejaculated sperm injection than after testicular sperm injection. Forty percent, 58%, 33%, and 46% of cycles had positive serum hCG using ejaculated, fresh, or frozen-thawed epididymal and testicular sperm. Initial pregnancy loss occurred in 26.3% of the conception cycles.
Intracytoplasmic sperm injection can provide high normal fertilization, cleavage, and PRs when fresh or frozen-thawed epididymal and testicular spermatozoa are used, but normal fertilization rates are significantly lower than after microinjection with ejaculated sperm.
描述用于卵胞浆内单精子注射的新鲜或冻融附睾精子和睾丸精子的制备方法,并将使用这些精子后的受精、胚胎质量及妊娠率与使用新鲜射出精子进行显微注射的结果进行比较。
对1034个连续显微注射周期进行回顾性分析。使用射出精子(965个周期)、新鲜附睾精子(43个周期)、冻融附睾精子(9个周期)和睾丸精子(17个周期)进行卵胞浆内精子注射。
在一家三级体外受精中心并结合机构研究环境进行操作。
根据世界卫生组织标准判断精液密度和活力,采用泰格堡严格标准评估精子形态。显微注射后,评估并比较卵母细胞完整性、受精、胚胎分裂、移植及妊娠率。
新鲜射出精子的精子总数、总活力及正常形态的中位数分别为17.85×10⁶、37%、8%;新鲜附睾精子为46.20×10⁶、12%、9%;冻融附睾精子为0.15×10⁶、0%、0%;睾丸精子为0.54×10⁶、0%(未测定形态)。显微注射后完整卵母细胞的百分比在84%至90%之间。当使用新鲜或冻融附睾精子和睾丸精子进行注射时,正常受精率较高(分别为56%、56%、48%),但显著低于射出精子(70%)。射出精子注射后获得的可移植胚胎比例高于睾丸精子注射后。使用射出精子、新鲜或冻融附睾精子和睾丸精子的周期中,分别有40%、58%、33%和46%出现血清人绒毛膜促性腺激素阳性。26.3%的受孕周期发生早期妊娠丢失。
当使用新鲜或冻融附睾精子和睾丸精子时,卵胞浆内精子注射可提供较高的正常受精、分裂及妊娠率,但正常受精率显著低于射出精子显微注射后。